GAMCO Investors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

GAMCO Investors’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-60,147	Closed	-$2.27M	–	963
2021 Q1	$2.27M	Buy	+60,147	New	+$1.5M	0.02%	493

GAMCO Investors's FPRX Position: Q2 2021 in Review

GAMCO Investors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 60,147 shares — an estimated $2.27M sold.

GAMCO Investors first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $2.27M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

GAMCO Investors reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
GAMCO Investors sold 60,147 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $2.27M.
GAMCO Investors first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
GAMCO Investors's Five Prime Therapeutics, Inc. position peaked at $2.27M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on GAMCO Investors's 13F filing for Q2 2021, filed 13 Aug 2021.